[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Intermittent Claudication Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 54 pages | ID: I1AD2B2526FEN
VPAResearch

US$ 700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Intermittent Claudication ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Intermittent Claudication disease clinical trials. The research work analyzes the ongoing Intermittent Claudication clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Intermittent Claudication treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Intermittent Claudication clinical trials.

Scope of the Report-
  • Ongoing Intermittent Claudication clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Intermittent Claudication
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Intermittent Claudication clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Intermittent Claudication Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Intermittent Claudication Trials by Phase
3.2 Ongoing Intermittent Claudication Trials by Type
3.3 Ongoing Intermittent Claudication Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Intermittent Claudication Trials
4.2 Top 10 Countries conducting Intermittent Claudication Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Intermittent Claudication Trials by Sponsor Type
5.2 Intermittent Claudication Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Intermittent Claudication Trials by year
6.2 Subjects Recruited for Intermittent Claudication Trials by Phase
6.3 Subjects Recruited for Intermittent Claudication Trials by Trial Type
6.4 Subjects Recruited for Intermittent Claudication Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Intermittent Claudication Trials- Phase
7.2 Ongoing Intermittent Claudication Trials- Phase
7.3 Ongoing Intermittent Claudication Trials- Phase
7.4 Ongoing Intermittent Claudication Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Intermittent Claudication- Clinical Trials by Country
Figure 2: Intermittent Claudication- Clinical Trials by Phase of Development, 2018
Figure 3: Intermittent Claudication- Clinical Trials by Status, 2018
Figure 4: Intermittent Claudication- Clinical Trials by Type, 2018
Figure 5: Intermittent Claudication- Clinical Trials Split by Region, 2000-2018
Figure 6: Intermittent Claudication- Clinical Trials by Type of Economy, 2018
Figure 7: Intermittent Claudication- Enrolment by Phase, 2018
Figure 8: Intermittent Claudication- Enrolment by Trial Type, 2018
Figure 9: Intermittent Claudication- Enrolment by Recruitment Status, 2018
Figure 10: Intermittent Claudication- Clinical Trials by Sponsor Type, 2018
Figure 11: Intermittent Claudication- Enrolment by Type of Sponsors
Figure 12: Intermittent Claudication- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Intermittent Claudication- Clinical Trials by Sponsor Type, 2018
Table 2: Intermittent Claudication- Clinical Trials by Economy Type, 2018
Table 3: Intermittent Claudication- Clinical Trials by Region, 2018
Table 4: Intermittent Claudication- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Intermittent Claudication- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Intermittent Claudication- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Intermittent Claudication- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Intermittent Claudication- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Intermittent Claudication- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications